Decentralized Cell Therapy Manufacturing
An ATMP Sweden webinar on the challenges of fresh, non-cryopreserved cell therapy product manufacturing and testing in a decentralized production model 
On June 3d 09:30-10:30, we will be joined by Karin Hoogendoorn to gain insights on considerations around decentralized manufacturing and testing models for cell therapy products, with attention to the unique challenges posed by working with fresh, non-cryopreserved materials.
With over 25 years of experience spanning the pharmaceutical industry and academia, Karin has played key roles in chemical, manufacturing, and controls (CMC) and CMC- regulatory affairs across the full lifecycle of ATMP development. Currently serving as CMC leader oncology at Galapagos BV, she brings a wealth of knowledge on CMC, including manufacturing strategies for cell and gene therapy products.
We will be joined by Kerstin Sollerbrant Melefors, Senior expert at Barncancerfonden, to moderate the session.
Register to attend here